General Information of the Compound
Compound ID |
CP0849449
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(R)-5-benzyl-3-((R)-1-(4-fluorophenyl)ethyl)-5-(5-morpholino-1H-benzo[d]imidazol-2-yl)oxazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C29H27FN4O4
|
||||||||||||||||||
Molecular Weight |
514.557
|
||||||||||||||||||
Canonical SMILES |
C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(N4CCOCC4)ccc3[nH]2)C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C29H27FN4O4/c1-19(21-7-9-22(30)10-8-21)34-27(35)29(38-28(34)36,18-20-5-3-2-4-6-20)26-31-24-12-11-23(17-25(24)32-26)33-13-15-37-16-14-33/h2-12,17,19H,13-16,18H2,1H3,(H,31,32)/t19-,29-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
IRAXFIAWXJVVGU-SONOPUAISA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Protein ID: PT00886, Estrogen receptor
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01154, Mineralocorticoid receptor
Protein ID: PT01172, Progesterone receptor